• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Document › Details

Centogene AG. (1/3/18). "Press Release: Centogene to Present at the 36th Annual J.P. Morgan Healthcare Conference". Rostock.

	Region	San Francisco, CA
	Country	United States (USA)
	Organisation	Centogene AG
	Group	Centogene (Group)
	Organisation 2	J.P. Morgan Securities LLC
	Group	JPMorgan Chase (Group)
	Product	J.P. Morgan 36th Annual Healthcare Conference 2018 San Francisco
	Product 2	CentoMD® rare disease variant database
	Index term	Centogene–JPMorgan Chase: investor conference, 201801 supply service Centogene presents at JP Morgan Healthcare Conference 2018
	Person	Arnold, Lauren (MacDougall Biomedical Communications 201801)

CENTOGENE, the worldwide leader in diagnosing, profiling, tracking and elucidating rare diseases for patients, clinicians and pharmaceutical partners, today announced that it will make a formal presentation at the 36th Annual J.P. Morgan Healthcare Conference. The company will provide a corporate update on Thursday, January 11, 2018 at 11:00 am PT.


About CENTOGENE

CENTOGENE unlocks the power of genetic insights to improve the quality of life of patients with genetic diseases. We achieve this through knowledge created by our worldwide diagnostic testing services incorporating global diversity, the world’s leading proprietary human genetic interpretation database, CentoMD® and solutions for pharmaceutical companies developing life-changing orphan drugs.

As one of the most diversified and largest genetic testing companies worldwide, CENTOGENE is dedicated to transforming the science of genetic information into solutions and hope for patients and their families. www.centogene.com; www.centoMD.com


Contacts

MacDougall Biomedical Communications
Lauren Arnold, 781-235-3060
larnold@macbiocom.com

Record changed: 2018-05-06

Advertisement

More documents for Centogene (Group)

• [1] Centogene AG. (5/29/18). "Press Release: Centogene Announces Agreement with Aldeyra Therapeutics for the Advancement of Novel Therapeutics for Patients with Sjögren-Larsson Syndrome". Rostock....
• [2] Centogene AG. (5/9/18). "Press Release: Centogene to Present at the Bio€quity Europe 2018 Conference". Rostock....
• [3] Centogene AG. (5/9/18). "Press Release: Centogene Announces Drug Development Collaboration with Orphazyme in Neuronopathic Gaucher Disease". Rostock....
• [4] Centogene AG. (5/4/18). "Press Release: Centogene Appoints Berndt Modig as New Supervisory Board Member". Rostock....
• [5] Centogene AG. (4/10/18). "Press Release: Centogene Expands Executive Team, Appoints Dr. Dirk Ehlers Chief Operating Officer". Rostock....
• [6] Qiagen N.V.. (10/9/17). "Press Release: Qiagen and Centogene to Collaborate in Bioinformatics for Genetic Diseases". Hilden, Rostock & Germantown, MD....
• [7] Centogene AG. (6/13/17). "Press Release: Centogene Raises a EUR 25 Million Series A Financing to Fuel Innovation and to Accelerate Growth into Personalized Medicine". Rostock & Berlin....
• [8] Centogene AG. (9/16/15). "Press Release: Prof. Peter Bauer as New Member in the Management Board at Centogene"....
• [9] Centogene AG. (6/1/14). "Press Release: Centogene CEO Position Changed – Michael Schlenk Hands Over to Founder Prof Arndt Rolfs". Rostock....
• [10] LifeLabs Medical Laboratory Services. (2/19/14). "Press Release: LifeLabs Medical Laboratory Services Acquires Centogene’s Canadian Business". Toronto, ON....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2018. Made in Germany.